Nurix Therapeutics discovers drugs that harness the body’s natural process to control protein levels. Our drugs control ubiquitin E3 ligases, the key enzymes responsible for protein breakdown in human cells, as a unique therapeutic approach called targeted protein modulation to treat a broad range of diseases. Our focus is on developing targeted therapies to treat cancer including novel, small molecule immuno-oncology agents.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
November 9, 2020
November 4, 2020
October 26, 2020
January 11 - January 14, 2021
J.P. Morgan 39th Annual Healthcare Conference (JPM 2021)
November 23, 2020 at 10:00 AM EST
Piper Sandler 32nd Annual Virtual Healthcare Conference
November 17, 2020 at 3:20 PM EST
Stifel 2020 Virtual Healthcare Conference